1 Almazov National Medical Research Centre, 2, Akkuratova st., Saint-Petersburg, 197341, Russia
2 North-Western State Medical University named after I.I. Mechnikov, Piskarevsky pr., Saint-Petersburg, 195067, Russia
3 NMRC of Oncology named after N.N.Petrov of MoH of Russia, Leningradskaya st., 68, Saint-Petersburg, 197758, Russia
Brief summary
Anti-Yo encephalitis is considered in the structure of paraneoplastic autoimmune neurological syndrome in the form of subacute cerebellar degeneration with the development of corresponding cerebellar symptoms. This disease is characterized by the development of an autoimmune lesion of the cerebellum with the production of cytoplasmic antibodies to type 1 Purkinje cells due to the presence of an oncological process in the patient's body. The aim of this work is to describe a clinical example of anti-Yo encephalitis with damage to the cerebellar vermis before the diagnosis of an oncological process in the mammary gland, which directly provoked the development of a paraneoplastic autoimmune neurological syndrome. Careful differential diagnosis in such cases helps to avoid unnecessary traumatic surgical intervention and contribute to a more extensive oncology search with subsequent identification of clinically significant foci of malignant neoplasms.
1) Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7:327.
2) Panzer J, Dalmau J. Movement disorders in paraneoplastic and autoimmune disease. Curr Opin Neurol. 2011;24:346-353.
3) Lancaster E, Dalmau J. Neuronal autoantigens: pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8:380-390.
4) Rojas I, Graus F, Keime-Guibert F, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000; 55:713.
5) Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003; 126:1409.
6) Dalmau J, Gonzalez RG, Lerwill MF. Case records of the Massachusetts General Hospital. Case 4-2007. A 56-year-old woman with rapidly progressive vertigo and ataxia. N Engl J Med 2007; 356:612.
7) J E Greenlee, H R Brashear. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983 Dec;14(6):609-13.
8) Debes JD, Lagarde SM, Hulsenboom E, et al. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction. Dig Surg 2007; 24:395.
10) Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993; 341:21.
11) Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev 2017; 97:839.
12) Graus F, Keime-Guibert F, Reñe R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124:1138.
13) Peterson K, Rosenblum MK, Kotanides H, et al. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992; 42:1931.
14) Josef Finsterer, Ursula Unterberger, Wolfgang Grisold. Asymptomatic persistence of anti-Yo antibodies for 5 years without relapse of malignancy. Wiley Online Library. Volume 27, Issue 3, June 2007, Pages 300-304.
15) Said S, Cooper CJ, Reyna E, et al. Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: case report and discussion. Am J Case Rep 2013;14:391-4.
16) Na-Yeon Jung, Kyoung-Nam Woo, Jae Wook Cho, et al. Anti-Yo-associated autoimmune encephalitis after colon cancer treatment. J Neurocrit Care 2020; 13(2): 105-108.